Journal Club
1. Spectrum Of Pulmonary Fungal Pathogens And Antifungal Drug Susceptibility Among TB Relapse And Retreatment Samples At Selected Health Facilities In Kenya - PhD Research Update
0
IAVI-W001 Study Launched at the KAVI-Institute of Clinical Research
On 24th September 2019, the first volunteer was enrolled in the IAVI-W001 study at the KAVI-Institute of Clinical Research (KAVI-ICR) of the University of Nairobi. The occasion marks the beginning of the 12th HIV vaccine clinical trial to be conducted at KAVI-ICR since 2001. This is a first-in-human study that uses a Native-trimer HIV envelope design that will hopefully stimulate broadly neutralizing antibodies against HIV.
0
Pinktober 2026: KAVI-ICR Joins Kenya in Marking Breast Cancer Awareness Month
Every October, the world turns pink. Pink ribbons, pink buildings and pink profile pictures mark Breast Cancer Awareness Month, a time to remember those we have lost, celebrate those living with and beyond breast cancer, and, most importantly, help more people find it early.